Clinical Trials in Arizona

Showing 4801-4820 of 16,770 trials

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

NCT02990481

1. To determine the maximum tolerated dose (MTD) and the dose limiting toxicities (DLTs) of TRK-950 as single agent 2. To establish the dose of TRK-950 recommended for future phase 2 studies

Locally Advanced or Metastatic Solid CarcinomasColon CancerCholangiocarcinoma

Toray Industries, Inc38 participantsStarted Mar 2017

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Lyon, France

COMPLETEDNA35 miles

StandUPTV: Reducing Sedentary Screen Time in Adults

NCT04464993

The goal of this study is to develop an optimized intervention for reducing leisure sedentary screen time (SST) in middle-aged adults with overweight or obesity. Investigators will use the multiphase optimization (MOST) framework to conduct a highly efficient full-factorial experimental study to simultaneously test the main effects for each of three intervention components (LOCKOUT, TEXT, EARN) and their interactions (e.g., TEXT+EARN; LOCKOUT+EARN+TEXT) over 16 weeks.

Sedentary BehaviorScreen TimePhysical Activity+1 more

Arizona State University110 participantsStarted Jun 2021

Tempe, Arizona, United States • San Luis Obispo, California, United States

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

StandUPTV: Reducing Sedentary Screen Time in Adults

Find Trials by Condition in Arizona

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Pramipexole to Enhance Social Connections

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial

An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

R3 Delta Ceramic Acetabular System PAS U.S.

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Tritanium® Primary Acetabular Shell Study